| LD Score regression distinguishes confounding from polygenicity in genome-wide association studies BK Bulik-Sullivan, PR Loh, HK Finucane, S Ripke, J Yang, ... Nature genetics 47 (3), 291-295, 2015 | 4241 | 2015 |
| Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma SA Rosenberg, BS Packard, PM Aebersold, D Solomon, SL Topalian, ... New England Journal of Medicine 319 (25), 1676-1680, 1988 | 3080 | 1988 |
| Acute effects and recovery time following concussion in collegiate football players: the NCAA Concussion Study M McCrea, KM Guskiewicz, SW Marshall, W Barr, C Randolph, RC Cantu, ... Jama 290 (19), 2556-2563, 2003 | 1867 | 2003 |
| New genetic loci link adipose and insulin biology to body fat distribution D Shungin, TW Winkler, DC Croteau-Chonka, T Ferreira, AE Locke, ... Nature 518 (7538), 187-196, 2015 | 1597 | 2015 |
| Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution IM Heid, AU Jackson, JC Randall, TW Winkler, L Qi, V Steinthorsdottir, ... Nature genetics 42 (11), 949-960, 2010 | 1097 | 2010 |
| Genetic variance estimation with imputed variants finds negligible missing heritability for human height and body mass index J Yang, A Bakshi, Z Zhu, G Hemani, AAE Vinkhuyzen, SH Lee, ... Nature genetics 47 (10), 1114-1120, 2015 | 842 | 2015 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 716 | 2021 |
| Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial L Paz-Ares, EH Tan, K O’Byrne, L Zhang, V Hirsh, M Boyer, JCH Yang, ... Annals of Oncology 28 (2), 270-277, 2017 | 558 | 2017 |
| Osimertinib As First-Line Treatment of EGFR Mutation–Positive Advanced Non–Small-Cell Lung Cancer SS Ramalingam, JCH Yang, CK Lee, T Kurata, DW Kim, T John, ... Journal of Clinical Oncology 36 (9), 841-849, 2018 | 526 | 2018 |
| Prevalence of and risk factors associated with symptoms of depression in competitive collegiate student athletes J Yang, C Peek-Asa, JD Corlette, G Cheng, DT Foster, J Albright Clinical journal of sport medicine 17 (6), 481-487, 2007 | 505 | 2007 |
| Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally … D Miles, J Gligorov, F André, D Cameron, A Schneeweiss, C Barrios, B Xu, ... Annals of Oncology 32 (8), 994-1004, 2021 | 436 | 2021 |
| Amivantamab in EGFR exon 20 insertion–mutated non–small-cell lung cancer progressing on platinum chemotherapy: initial results from the CHRYSALIS phase I study K Park, EB Haura, NB Leighl, P Mitchell, CA Shu, N Girard, S Viteri, ... Journal of Clinical Oncology 39 (30), 3391, 2021 | 426 | 2021 |
| Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study A Bhangu, AO Ademuyiwa, ML Aguilera, P Alexander, SW Al-Saqqa, ... The Lancet Infectious Diseases 18 (5), 516-525, 2018 | 409 | 2018 |
| The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo. JJ Mule, S Shu, SA Rosenberg Journal of immunology (Baltimore, Md.: 1950) 135 (1), 646-652, 1985 | 404 | 1985 |
| The power of genetic diversity in genome-wide association studies of lipids SE Graham, SL Clarke, KHH Wu, S Kanoni, GJM Zajac, S Ramdas, ... Nature 600 (7890), 675-679, 2021 | 396 | 2021 |
| Incidence and risk factors for concussion in high school athletes, North Carolina, 1996–1999 MR Schulz, SW Marshall, FO Mueller, J Yang, NL Weaver, WD Kalsbeek, ... American journal of epidemiology 160 (10), 937-944, 2004 | 376 | 2004 |
| Epidemiology of overuse and acute injuries among competitive collegiate athletes J Yang, AS Tibbetts, T Covassin, G Cheng, S Nayar, E Heiden Journal of athletic training 47 (2), 198-204, 2012 | 370 | 2012 |
| TATTON: a multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer GR Oxnard, JCH Yang, H Yu, SW Kim, H Saka, L Horn, K Goto, Y Ohe, ... Annals of Oncology 31 (4), 507-516, 2020 | 335 | 2020 |
| Quantifying and modelling fabric anisotropy of granular soils ZX Yang, XS Li, J Yang Géotechnique 58 (4), 237-248, 2008 | 328 | 2008 |
| Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189 D Rodríguez-Abreu, SF Powell, MJ Hochmair, S Gadgeel, E Esteban, ... Annals of Oncology 32 (7), 881-895, 2021 | 315 | 2021 |
